经翔,周燕,丁建民,王彦冬,周洪雨.经皮热消融治疗肝脏恶性肿瘤Glisson系统相关并发症分析[J].中国介入影像与治疗学,2018,15(1):19-23
经皮热消融治疗肝脏恶性肿瘤Glisson系统相关并发症分析
Glisson system-related complications after percutaneous thermal ablation of liver cancer
投稿时间:2017-08-07  修订日期:2017-12-14
DOI:10.13929/j.1672-8475.201708011
中文关键词:  导管消融术    肝细胞  Glisson系统  并发症
英文关键词:Catheter ablation  Carcinoma  hepatocellular  Glisson system  Complications
基金项目:天津市卫生局科技基金(2013KY03)。
作者单位E-mail
经翔 天津市第三中心医院超声科, 天津 300170
天津市肝胆疾病研究所 天津市人工细胞重点实验室 卫生部人工细胞工程技术研究中心, 天津 300170 
dr.jingxiang@aliyun.com 
周燕 天津市第三中心医院超声科, 天津 300170
天津市肝胆疾病研究所 天津市人工细胞重点实验室 卫生部人工细胞工程技术研究中心, 天津 300170 
 
丁建民 天津市第三中心医院超声科, 天津 300170
天津市肝胆疾病研究所 天津市人工细胞重点实验室 卫生部人工细胞工程技术研究中心, 天津 300170 
 
王彦冬 天津市第三中心医院超声科, 天津 300170
天津市肝胆疾病研究所 天津市人工细胞重点实验室 卫生部人工细胞工程技术研究中心, 天津 300170 
 
周洪雨 天津市第三中心医院超声科, 天津 300170
天津市肝胆疾病研究所 天津市人工细胞重点实验室 卫生部人工细胞工程技术研究中心, 天津 300170 
 
摘要点击次数: 1519
全文下载次数: 665
中文摘要:
      目的 探讨经皮热消融治疗肝脏恶性肿瘤术后Glisson系统相关并发症发生率及与肿瘤位置的关系。方法 回顾性分析1 879例肝脏恶性肿瘤患者共2 218例次超声引导下经皮热消融治疗的资料。根据肿瘤与Glisson系统的位置关系分为4类,肿瘤邻近1、2、3级门静脉分支分别定义为Ⅰ、Ⅱ、Ⅲ类(邻近Glisson系统组),远离门静脉定义为Ⅳ类(非邻近Glisson系统组)。分析并发症(胆脂瘤、胆漏、胆管严重狭窄、胆管-支气管瘘、动脉-门静脉瘘及动脉瘤)的发生情况。结果 共20例次(20/2 218,0.90%)患者发生Glisson系统相关严重并发症。邻近Glisson系统组Glisson系统相关严重并发症发生率[1.81%(16/886)]高于非邻近Glisson系统组[0.30%(4/1 332),P<0.001]。Ⅰ、Ⅱ、Ⅲ、Ⅳ类患者Glisson系统相关严重并发症发生率[6.35%(4/63)、3.52%(5/142)、1.03%(7/681)、0.30%(4/1 332)]差异有统计学意义(P<0.001)。Glisson系统相关轻微并发症包括肝功能损伤(280例次)、门静脉血栓形成(156例次)及消融区末梢胆管扩张(82例次),且发生率在Ⅰ~Ⅳ类患者中呈逐渐降低的趋势。结论 经皮热消融治疗具有较高的安全性,但Glisson系统相关严重并发症的发生率随肿瘤靠近上级门静脉分支有增高趋势。
英文摘要:
      Objective To analyze Glisson system-related complications after percutaneous thermal ablation of liver cancer and the relationship with tumor location. Methods Data of 2 218 case-times of ultrasound-guided percutaneous thermal ablation in 1 879 patients with liver cancer were retrospectively analyzed. Four types were defined according to the relative position between the tumor and Glisson system:Tumor close to the first branch of the portal vein (type Ⅰ), the second branch of the portal vein (type Ⅱ), the third branch of the portal vein (type Ⅲ) and far away from portal vein (type Ⅳ). Types Ⅰ to Ⅲ were classified as close to Glisson system group, while type Ⅳ was classified as far away from Glisson system group. The Glisson system-related complications (cholesteatoma, bile leakage, serious biliary stricture, cholangio-bronchial fistula, arterio-venous fistula and arterial aneurysm) were analyzed. Results Glisson system-related severe complications occurred after 20 case-times (20/2 218, 0.90%) of thermal ablation. The incidence of Glisson system-related severe complications in close to Glisson system group (1.81%[16/886]) was higher than that in far away from Glisson system group (0.30%[4/1 332], P<0.001). The incidence of Glisson system-related severe complications of type Ⅰ, Ⅱ, Ⅲ and Ⅳ was 6.35% (4/63), 3.52% (5/142), 1.03% (7/681) and 0.30% (4/1 332), respectively (P<0.001). Glisson system-related mild complications included liver function damage (280 case-times), portal thrombosis (156 case-times) and slight cholangiectasis (82 case-times). The incidences of the three Glisson system-related complications mentioned above decreased from type Ⅰ to Ⅳ. Conclusion Percutaneous thermal ablation is safe in treating patients with tumors close to Glisson system. But the risk of incidence of Glisson system-related severe complications is higher when the tumor is close to the more advanced branch of portal vein.
查看全文  查看/发表评论  下载PDF阅读器
关闭